Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Boloc

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Psychiatric Research|May 15, 2020
The positive allosteric modulator of the mGlu2 receptor JNJ-46356479 partially improves neuropathological deficits and schizophrenia-like behaviors in a postnatal ketamine mice modelAlbert Martínez-Pinteño, Susana García-Cerro, Sergi Mas, et al.
Journal of Neuroinflammation|December 30, 2017
Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorderNatalia Rodríguez, Astrid Morer, E Azucena González-Navarro, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 1, 2017
Association of regulatory TPH2 polymorphisms with higher reduction in depressive symptoms in children and adolescents treated with fluoxetinePatricia Gassó, Natalia Rodríguez, Daniel Boloc, et al.
American Journal of Translational Research|June 9, 2020
Response to fluoxetine in children and adolescents: a weighted gene co-expression network analysis of peripheral bloodTeresa Torres, Daniel Boloc, Natalia Rodríguez, et al.
Brain, Behavior, and Immunity|July 26, 2019
Altered frequencies of Th17 and Treg cells in children and adolescents with obsessive-compulsive disorderNatalia Rodríguez, Astrid Morer, E Azucena González-Navarro, et al.
Translational Psychiatry|May 4, 2019
Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychoticsDaniel Boloc, Anna Gortat, Jia Qi Cheng-Zhang, et al.
Psychopharmacology|May 9, 2020
Identifying key transcription factors for pharmacogenetic studies of antipsychotics induced extrapyramidal symptomsDaniel Boloc, Natalia Rodríguez, Teresa Torres, et al.
Translational Psychiatry|December 15, 2018
Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychoticsDaniel Boloc, Anna Gortat, Jia Qi Cheng-Zhang, et al.
Psychiatry Research|September 14, 2016
Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disordersPatricia Gassó, Vanessa Sánchez-Gistau, Sergi Mas, et al.
Schizophrenia Bulletin|February 22, 2020
Examining Gene-Environment Interactions Using Aggregate Scores in a First-Episode Psychosis CohortSergi Mas, Daniel Boloc, Natalia Rodríguez, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Psychiatric Research|May 15, 2020
The positive allosteric modulator of the mGlu2 receptor JNJ-46356479 partially improves neuropathological deficits and schizophrenia-like behaviors in a postnatal ketamine mice modelAlbert Martínez-Pinteño, Susana García-Cerro, Sergi Mas, et al.
Journal of Neuroinflammation|December 30, 2017
Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorderNatalia Rodríguez, Astrid Morer, E Azucena González-Navarro, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 1, 2017
Association of regulatory TPH2 polymorphisms with higher reduction in depressive symptoms in children and adolescents treated with fluoxetinePatricia Gassó, Natalia Rodríguez, Daniel Boloc, et al.
American Journal of Translational Research|June 9, 2020
Response to fluoxetine in children and adolescents: a weighted gene co-expression network analysis of peripheral bloodTeresa Torres, Daniel Boloc, Natalia Rodríguez, et al.
Brain, Behavior, and Immunity|July 26, 2019
Altered frequencies of Th17 and Treg cells in children and adolescents with obsessive-compulsive disorderNatalia Rodríguez, Astrid Morer, E Azucena González-Navarro, et al.
Translational Psychiatry|May 4, 2019
Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychoticsDaniel Boloc, Anna Gortat, Jia Qi Cheng-Zhang, et al.
Psychopharmacology|May 9, 2020
Identifying key transcription factors for pharmacogenetic studies of antipsychotics induced extrapyramidal symptomsDaniel Boloc, Natalia Rodríguez, Teresa Torres, et al.
Translational Psychiatry|December 15, 2018
Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychoticsDaniel Boloc, Anna Gortat, Jia Qi Cheng-Zhang, et al.
Psychiatry Research|September 14, 2016
Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disordersPatricia Gassó, Vanessa Sánchez-Gistau, Sergi Mas, et al.
Schizophrenia Bulletin|February 22, 2020
Examining Gene-Environment Interactions Using Aggregate Scores in a First-Episode Psychosis CohortSergi Mas, Daniel Boloc, Natalia Rodríguez, et al.
Pageof 3